Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | Sunitinib |
Trade Name | Sutent |
Synonyms | SU011248 |
Drug Descriptions |
Sutent (sunitinib) inhibits KDR (VEGFR2), PDGFR, c-KIT, FLT3, RET, and CSF1R, thereby inhibiting angiogenesis and cell proliferation (PMID: 25085632). Sutent (sunitinib) is approved for neuroendocrine tumors of the pancreas, advanced renal cell carcinoma, and GIST (FDA.gov). |
DrugClasses | CSF1R Inhibitor 26 FLT3 Inhibitor 57 KIT Inhibitor 52 PDGFR Inhibitor (Pan) 27 RET Inhibitor 43 VEGFR2 Inhibitor 35 |
CAS Registry Number | 557795-19-4 |
NCIT ID | C71622 |